Bill Ringo Joins Sofinnova Ventures

Bill Ringo has joined Sofinnova Ventures as an executive-in-residence, focused on the life sciences market. He is the former president and CEO of Abgenix Inc., which was sold to Amgen last year for $2.7 billion. www.sofinnova.com